These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Principles of immunotherapy in insulin-dependent diabetes mellitus]. Bretzel RG Wien Klin Wochenschr; 1988 Jun; 100(13):435-42. PubMed ID: 3043913 [TBL] [Abstract][Full Text] [Related]
24. Strategies in immunotherapy of insulin-dependent diabetes mellitus. Bach JF Ann N Y Acad Sci; 1993 Nov; 696():364-76. PubMed ID: 8109843 [TBL] [Abstract][Full Text] [Related]
25. Protective and destructive effects of microbial infection in insulin-dependent diabetes mellitus. Singh B; Prange S; Jevnikar AM Semin Immunol; 1998 Feb; 10(1):79-86. PubMed ID: 9529658 [TBL] [Abstract][Full Text] [Related]
26. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus. Phillips BE; Giannoukakis N; Trucco M Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749 [TBL] [Abstract][Full Text] [Related]
27. Nicotinamide trials in diabetes intervention. Does a metabolite provide benefit? Gosteli J Med Hypotheses; 2005; 64(5):1062-3. PubMed ID: 15780513 [No Abstract] [Full Text] [Related]
28. Nicotinamide in type 1 diabetes. Mechanism of action revisited. Kolb H; Burkart V Diabetes Care; 1999 Mar; 22 Suppl 2():B16-20. PubMed ID: 10097894 [TBL] [Abstract][Full Text] [Related]
29. Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. Sempé P; Bédossa P; Richard MF; Villà MC; Bach JF; Boitard C Eur J Immunol; 1991 May; 21(5):1163-9. PubMed ID: 1828030 [TBL] [Abstract][Full Text] [Related]
30. T-cell regulation in murine and human autoimmune diabetes: the role of TH1 and TH2 cells. Heurtier AH; Boitard C Diabetes Metab; 1997 Nov; 23(5):377-85. PubMed ID: 9416429 [TBL] [Abstract][Full Text] [Related]
31. Insulin and the prevention of insulin-dependent diabetes mellitus. Coutant R; Carel JC; Timsit J; Boitard C; Bougnères P Diabetes Metab; 1997 Sep; 23 Suppl 3():25-8. PubMed ID: 9342539 [TBL] [Abstract][Full Text] [Related]
32. Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin requirement after 2 years. Pozzilli P; Visalli N; Buzzetti R; Baroni MG; Boccuni ML; Fioriti E; Signore A; Mesturino C; Valente L; Cavallo MG Diabete Metab; 1995 Feb; 21(1):47-9. PubMed ID: 7781843 [TBL] [Abstract][Full Text] [Related]
33. Residual B cell activity and insulin requirements in insulin-dependent diabetic patients treated from the beginning with high doses of nicotinamide. A two-year follow-up. Taboga C; Tonutti L; Noacco C Recenti Prog Med; 1994 Nov; 85(11):513-6. PubMed ID: 7855383 [TBL] [Abstract][Full Text] [Related]
34. [Immuno- and regeneration therapy of recently diagnosed diabetes mellitus type I]. Huth E Klin Padiatr; 1985; 197(2):75-84. PubMed ID: 3157826 [TBL] [Abstract][Full Text] [Related]
35. Prevention and ethics in medicine: the case of diabetes prevention. Nordenfelt L J Pediatr Endocrinol Metab; 1996; 9(3):381-6. PubMed ID: 8887147 [TBL] [Abstract][Full Text] [Related]
36. Intensive insulin therapy justifies simplification of the diabetes diet: a prospective study in insulin-dependent diabetic patients. Venhaus A Am J Clin Nutr; 1988 Jan; 47(1):162-3. PubMed ID: 3276134 [No Abstract] [Full Text] [Related]
40. [Influence of nicotinamide on the course of insulin-dependent diabetes mellitus]. Kretowski A; Kinalska I Pol Arch Med Wewn; 1994 Aug; 92(2):162-9. PubMed ID: 7800585 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]